实体肿瘤患者伴发肺炎临床诊疗实践中国专家共识(2024版)  

Chinese expert consensus on diagnosis,treatment and prevention of pulmonary infection in patients with solid tumors(2024 edition)

作　　者：中国抗癌协会肿瘤呼吸病学专业委员会 曹彬 张静[3] 杨萌[4] 佘丹阳[5] 周华[6] 李园园[7] 王一民[4] 陆海雯[8] 文文 崔晓敬[4] 程瑞瑞[10] 刘智博[4] Oncology Respiratory Disease Committee of China Anti-Cancer Association;Cao Bin;Zhang Jing;Yang Meng(不详;National Center for Respiratory Medicine/State Key Laboratory of Respiratory Health and Multimorbidity/National Clinical Research Center for Respiratory Diseases/Institute of Respiratory Medicine,Chinese Academy of Medical Sciences/Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China;Department of Respiratory and Critical Care Medicine,Zhongshan Hospital Affiliated to Fudan University,Shanghai 200032,China;Department of Respiratory and Critical Care Medicine,China-Japan Friendship Hospital,Beijing 100029,China)

机构地区：[1]不详 [2]国家呼吸医学中心,呼吸和共病全国重点实验室,国家呼吸疾病临床研究中心,中国医学科学院呼吸病学研究院,中日友好医院呼吸中心,北京100029 [3]复旦大学附属中山医院呼吸与危重症医学科,上海200032 [4]中日友好医院呼吸与危重症医学科,北京100029 [5]解放军总医院呼吸与危重症医学部 [6]浙江大学医学院附属第一医院呼吸与危重症医学科 [7]中南大学湘雅医院呼吸与危重症医学科 [8]同济大学附属上海市肺科医院呼吸与危重症医学科 [9]联勤保障部队第九○○医院呼吸与危重症医学科 [10]郑州大学第一附属医院呼吸与危重症医学科

出　　处：《中华肿瘤杂志》2024年第12期1156-1175,共20页Chinese Journal of Oncology

基　　金：中国医学科学院医学科学创新基金(2021-I2M-1-048、2021-1-I2M-012);新基石科学基金(NCI202231);国家自然科学基金(82241056、82030002)。

摘　　要：实体肿瘤患者在接受临床诊治中伴发肺炎发病风险升高,其预防、诊断和治疗均存在不同于一般人群的特点,包括特定肺炎危险因素的纠正、预防性抗感染药物的合理应用、肿瘤治疗相关肺部不良反应的鉴别、侵入性采样诊断技术的应用策略、经验性抗感染治疗中的病原及耐药性考量等。为了规范实体肿瘤患者伴发肺炎的诊治和预防,中国抗癌协会肿瘤呼吸病学专业委员会发起制定《实体肿瘤患者伴发肺炎临床诊疗实践中国专家共识(2024版)》,在梳理该领域最新证据的基础上提出诊疗路径和推荐意见。共识适用于从事成人实体肿瘤诊治的肿瘤科以及呼吸科、感染科、外科、急诊科、老年科和全科的医护人员。Patients with solid tumors have an increased risk of developing pneumonia during the management of tumor.The prevention,diagnosis,and treatment of pneumonia in these patients have different characteristics compared to the general population,such as the correction of specific risk factors for pneumonia,the rational use of prophylactic antimicrobial drugs,the strategy of invasive sampling diagnostic techniques application,the differential diagnosis from anti-tumor treatment associated pulmonary adverse events,and the consideration of pathogens and drug resistance in empirical antimicrobial treatment.In order to standardize the diagnosis,treatment,and prevention of pneumonia in patients with solid tumors,Oncology Respiratory Disease Committee of China Anti-Cancer Association initiated the"Chinese expert consensus on the diagnosis and treatment of pneumonia in patients with solid tumors(2024 edition)".Based on a review of the latest evidence in this field,the consensus provides diagnostic and treatment pathways as well as recommendations.This consensus applies to oncologists,pulmonologists,infectious disease physicians,surgeons,emergency medicine physicians,and general practice healthcare professionals involved in the management of solid tumors in adults.

关 键 词：恶性肿瘤 肺炎 诊断 治疗 预防 专家共识 

分 类 号：R730.5[医药卫生—肿瘤]